Last 12 months
Inside the activity.
10 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 5 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 5 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2017 Filed Jan 10, 2017 21:30 UTC |
Golden RandalVP, General Counsel
|
Exercise / conversionCommon Stock | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001437 · form4.xml · nonDerivative · entry 3 Golden Randal · CIK 0001598001 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:30 UTC |
Golden RandalVP, General Counsel
|
Tax withholdingCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001437 · form4.xml · nonDerivative · entry 2 Golden Randal · CIK 0001598001 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,344 F1 · shares: 1/8/2017 RSU/PSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/6/2017) of $177.21 was used. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:30 UTC |
Golden RandalVP, General Counsel
|
Exercise / conversionCommon Stock | 501 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001437 · form4.xml · nonDerivative · entry 1 Golden Randal · CIK 0001598001 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
Exercise / conversionRestricted Stock Units · Derivative | 401 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · derivative · entry 9 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204 Underlying: Common Stock · 401 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F7 · derivative.exercise_date: 12/9/14 RSU Grant - Vesting Date: The grant vests in equal portions on the following dates: 1/8/16, 1/8/17, 1/8/18, 1/8/19 and 1/8/20. F4 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
Exercise / conversionRestricted Stock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · derivative · entry 8 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,086 Underlying: Common Stock · 544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F5 · derivative.exercise_date: Grant Date 12/11/13 RSU Vesting Date: The grant vests in equal portions on the following dates: 1/8/15, 1/8/16, 1/8/17, 1/8/18 and 1/8/19. F6 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
Exercise / conversionRestricted Stock Units · Derivative | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · derivative · entry 7 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680 Underlying: Common Stock · 680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F3 · derivative.exercise_date: Grant Date 12/12/12 RSU Vesting Date: The grant vests in equal portions on the following dates: 1/8/14, 1/8/15, 1/8/16, 1/8/17 and 1/8/18. F4 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
Tax withholdingCommon Stock | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 6 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,016 F1 · shares: 1/8/2017 RSU/PSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/6/2017) of $177.21 was used. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
Exercise / conversionCommon Stock | 401 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 5 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
Tax withholdingCommon Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 4 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,753 F1 · shares: 1/8/2017 RSU/PSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/6/2017) of $177.21 was used. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
Exercise / conversionCommon Stock | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 3 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
Tax withholdingCommon Stock | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 2 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,395 F1 · shares: 1/8/2017 RSU/PSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/6/2017) of $177.21 was used. Read SEC document |
| January 08, 2017 Filed Jan 10, 2017 21:24 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
Exercise / conversionCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001435 · form4.xml · nonDerivative · entry 1 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 21:45 UTC |
RUBENSTEIN ALLAN EDirector
|
Exercise / conversionNon-employee Director Stock Option (Right to Buy) · Derivative | 4,950 | $0.00 Strike: $98.45 | $0.00 |
DisclosureSEC source: 0001127602-17-001444 · form4.xml · derivative · entry 3 RUBENSTEIN ALLAN E · CIK 0001182773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,950 shares Expires 2022-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 21:45 UTC |
RUBENSTEIN ALLAN EDirector
|
SaleCommon Stock | 4,950 | $177.00 | $876,150.00 |
DisclosureSEC source: 0001127602-17-001444 · form4.xml · nonDerivative · entry 2 RUBENSTEIN ALLAN E · CIK 0001182773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,794 Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 21:45 UTC |
RUBENSTEIN ALLAN EDirector
|
Exercise / conversionCommon Stock | 4,950 | $98.45 | $487,327.50 |
DisclosureSEC source: 0001127602-17-001444 · form4.xml · nonDerivative · entry 1 RUBENSTEIN ALLAN E · CIK 0001182773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2017 Filed Jan 5, 2017 23:51 UTC |
PETERSMEYER GARY SDirector
|
SaleCommon Stock | 458 | $175.97 | $80,595.18 |
DisclosureSEC source: 0001127602-17-001181 · form4.xml · nonDerivative · entry 1 PETERSMEYER GARY S · CIK 0001206986 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Gary and Catherine Petersmeyer Trust DTD Disclosed balance after: 1,071 F1 · price: Sale price represents an average sale price between $175.971 and $175.973. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:35 UTC |
BENDER A THOMASDirector
|
Exercise / conversionNon-employee Director Stock Option (Right to Buy) · Derivative | 8,250 | $0.00 Strike: $28.52 | $0.00 |
DisclosureSEC source: 0001127602-17-000746 · form4.xml · derivative · entry 4 BENDER A THOMAS · CIK 0001182195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,250 shares Expires 2019-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:35 UTC |
BENDER A THOMASDirector
|
SaleCommon Stock | 8,250 | $175.56 | $1,448,351.03 |
DisclosureSEC source: 0001127602-17-000746 · form4.xml · nonDerivative · entry 2 BENDER A THOMAS · CIK 0001182195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,978 F1 · price: Sale price represents an average of the sale prices between $175.534 and $175.561. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:35 UTC |
BENDER A THOMASDirector
|
Exercise / conversionCommon Stock | 8,250 | $28.52 | $235,290.00 |
DisclosureSEC source: 0001127602-17-000746 · form4.xml · nonDerivative · entry 1 BENDER A THOMAS · CIK 0001182195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:32 UTC |
KALKSTEIN MICHAELDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $42.49 | $0.00 |
DisclosureSEC source: 0001127602-17-000742 · form4.xml · derivative · entry 5 KALKSTEIN MICHAEL · CIK 0001183216 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Kalkstein and English Family Trust u/a/d May 18, 2005, as amended Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires 2017-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: All shares granted under this option are currently exercisable. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:32 UTC |
KALKSTEIN MICHAELDirector
|
SaleCommon Stock | 6,393 | $175.40 | $1,121,332.20 |
DisclosureSEC source: 0001127602-17-000742 · form4.xml · nonDerivative · entry 3 KALKSTEIN MICHAEL · CIK 0001183216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 899 F2 · price: Sale price represents an average of sale prices ranging from $175.000 to $175.960. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:32 UTC |
KALKSTEIN MICHAELDirector
|
SaleCommon Stock | 2,607 | $174.82 | $455,755.74 |
DisclosureSEC source: 0001127602-17-000742 · form4.xml · nonDerivative · entry 2 KALKSTEIN MICHAEL · CIK 0001183216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,292 F1 · price: Sale price represents an average of sale prices ranging from $174.625 to $174.940. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:32 UTC |
KALKSTEIN MICHAELDirector
|
Exercise / conversionCommon Stock | 9,000 | $42.49 | $382,410.00 |
DisclosureSEC source: 0001127602-17-000742 · form4.xml · nonDerivative · entry 1 KALKSTEIN MICHAEL · CIK 0001183216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2016 Filed Jan 10, 2017 21:42 UTC |
KAUFMAN CAROL REVP, Sec. & Chief Gov. Officer
|
GiftCommon Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001440 · form4.xml · nonDerivative · entry 1 KAUFMAN CAROL R · CIK 0001181958 · EVP, Sec. & Chief Gov. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,640 Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 00:28 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $42.65 | $0.00 |
DisclosureSEC source: 0001127602-16-070723 · form4.xml · derivative · entry 4 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-fourth shall vest on the earlier of (a) 10/25/08 or (b) when the average closing price reaches $47.77; one-fourth shall vest on the earlier of (a) 10/25/09 or (b) when the average closing price reaches $51.18; one-fourth shall vest on the earlier of (a) 10/25/10 or (b) when the average closing price reaches $55.45; and one-fourth shall vest on the earlier of (a) 10/25/11 or (b) when the average closing price reaches $59.71. Average Closing Price is defined as the average of the closing prices of a share of common stock of the Company on the New York Stock Exchange (composite quotations, rounded to the nearest whole cent) for the days on which the common stock is so traded, during any 30 consecutive calendar day period commencing on the date the specified stock target is achieved. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 00:28 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
SaleCommon Stock | 20,000 | $174.82 | $3,496,392.00 |
DisclosureSEC source: 0001127602-16-070723 · form4.xml · nonDerivative · entry 2 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,644 F1 · price: Sale price represents an average of the selling prices between $174.39 and $175.155. Read SEC document |
| December 20, 2016 Filed Dec 22, 2016 00:28 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Exercise / conversionCommon Stock | 20,000 | $42.65 | $853,000.00 |
DisclosureSEC source: 0001127602-16-070723 · form4.xml · nonDerivative · entry 1 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:57 UTC |
Golden RandalVP, General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,999 | $0.00 Strike: $175.31 | $0.00 |
DisclosureSEC source: 0001127602-16-070158 · form4.xml · derivative · entry 2 Golden Randal · CIK 0001598001 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,999 Underlying: Common Stock · 9,999 shares Expires 2026-12-13 F1 · derivative.exercise_date: 12/13/16 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/17; 1/5 shall vest on 12/13/18; 1/5 shall vest on 12/13/19; 1/5 shall vest on 12/13/20 and 1/5 shall vest on 12/13/21. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:58 UTC |
Maloney TinaVP, Corporate Controller
|
GrantRestricted Stock Units · Derivative | 713 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-070159 · form4.xml · derivative · entry 3 Maloney Tina · CIK 0001595139 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713 Underlying: Common Stock · 713 shares Expires not disclosed F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F3 · derivative.exercise_date: 12/13/16 RSU Grant - Vesting Date: The grant vests in equal portions on the following dates: 1/8/18, 1/8/19, 1/8/20, 1/8/21 and 1/8/22. F4 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:58 UTC |
Maloney TinaVP, Corporate Controller
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,841 | $0.00 Strike: $175.31 | $0.00 |
DisclosureSEC source: 0001127602-16-070159 · form4.xml · derivative · entry 2 Maloney Tina · CIK 0001595139 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,841 Underlying: Common Stock · 2,841 shares Expires 2026-12-13 F1 · derivative.exercise_date: 12/13/16 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/17; 1/5 shall vest on 12/13/18; 1/5 shall vest on 12/13/19; 1/5 shall vest on 12/13/20 and 1/5 shall vest on 12/13/21. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:51 UTC |
White Albert G IIIEVP, CFO & CSO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 28,748 | $0.00 Strike: $175.31 | $0.00 |
DisclosureSEC source: 0001127602-16-070156 · form4.xml · derivative · entry 2 White Albert G III · CIK 0001357705 · EVP, CFO & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,748 Underlying: Common Stock · 28,748 shares Expires 2026-12-13 F1 · derivative.exercise_date: 12/13/16 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/17; 1/5 shall vest on 12/13/18; 1/5 shall vest on 12/13/19; 1/5 shall vest on 12/13/20 and 1/5 shall vest on 12/13/21. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:55 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
GrantRestricted Stock Units · Derivative | 1,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-070157 · form4.xml · derivative · entry 3 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,858 Underlying: Common Stock · 1,858 shares Expires not disclosed F3 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F4 · derivative.exercise_date: 12/13/16 RSU Grant - Vesting Date: The grant vests in equal portions on the following dates: 1/8/18, 1/8/19, 1/8/20, 1/8/21 and 1/8/22. F5 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:55 UTC |
REMMELL PAUL LPres & CEO - CooperSurgical
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,403 | $0.00 Strike: $175.31 | $0.00 |
DisclosureSEC source: 0001127602-16-070157 · form4.xml · derivative · entry 2 REMMELL PAUL L · CIK 0001182669 · Pres & CEO - CooperSurgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,403 Underlying: Common Stock · 7,403 shares Expires 2026-12-13 F2 · derivative.exercise_date: 12/13/16 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/17; 1/5 shall vest on 12/13/18; 1/5 shall vest on 12/13/19; 1/5 shall vest on 12/13/20 and 1/5 shall vest on 12/13/21. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:50 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 28,748 | $0.00 Strike: $175.31 | $0.00 |
DisclosureSEC source: 0001127602-16-070155 · form4.xml · derivative · entry 3 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,748 Underlying: Common Stock · 28,748 shares Expires 2026-12-13 F1 · derivative.exercise_date: 12/13/16 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/17; 1/5 shall vest on 12/13/18; 1/5 shall vest on 12/13/19; 1/5 shall vest on 12/13/20 and 1/5 shall vest on 12/13/21. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:47 UTC |
KAUFMAN CAROL REVP, Sec. & Chief Gov. Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 21,740 | $0.00 Strike: $175.31 | $0.00 |
DisclosureSEC source: 0001127602-16-070154 · form4.xml · derivative · entry 2 KAUFMAN CAROL R · CIK 0001181958 · EVP, Sec. & Chief Gov. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,740 Underlying: Common Stock · 21,740 shares Expires 2026-12-13 F1 · derivative.exercise_date: 12/13/16 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/17; 1/5 shall vest on 12/13/18; 1/5 shall vest on 12/13/19; 1/5 shall vest on 12/13/20 and 1/5 shall vest on 12/13/21. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 22:45 UTC |
WEISS ROBERT SDirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 79,370 | $0.00 Strike: $175.31 | $0.00 |
DisclosureSEC source: 0001127602-16-070153 · form4.xml · derivative · entry 2 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,370 Underlying: Common Stock · 79,370 shares Expires 2026-12-13 F1 · derivative.exercise_date: 12/13/16 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/17; 1/5 shall vest on 12/13/18; 1/5 shall vest on 12/13/19; 1/5 shall vest on 12/13/20 and 1/5 shall vest on 12/13/21. Read SEC document |
| December 12, 2016 Filed Dec 15, 2016 22:47 UTC |
KAUFMAN CAROL REVP, Sec. & Chief Gov. Officer
|
GiftCommon Stock | 38 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-070154 · form4.xml · nonDerivative · entry 1 KAUFMAN CAROL R · CIK 0001181958 · EVP, Sec. & Chief Gov. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,655 Read SEC document |
| November 15, 2016 Filed Nov 16, 2017 23:35 UTC |
BENDER A THOMASDirector
|
GrantRestricted Stock Units · Derivative | 1,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032459 · form4.xml · derivative · entry 3 BENDER A THOMAS · CIK 0001182195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,727 Underlying: Common Stock · 1,727 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2016 Filed Nov 16, 2017 23:40 UTC |
KALKSTEIN MICHAELDirector
|
GrantRestricted Stock Units · Derivative | 1,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032460 · form4.xml · derivative · entry 3 KALKSTEIN MICHAEL · CIK 0001183216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570 Underlying: Common Stock · 1,570 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2016 Filed Nov 16, 2017 23:30 UTC |
ZINBERG STANLEY MDDirector
|
GrantRestricted Stock Units · Derivative | 1,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032457 · form4.xml · derivative · entry 2 ZINBERG STANLEY MD · CIK 0001182041 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570 Underlying: Common Stock · 1,570 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2016 Filed Nov 16, 2017 23:24 UTC |
RUBENSTEIN ALLAN EDirector
|
GrantRestricted Stock Units · Derivative | 1,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032456 · form4.xml · derivative · entry 2 RUBENSTEIN ALLAN E · CIK 0001182773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649 Underlying: Common Stock · 1,649 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2016 Filed Nov 16, 2017 23:20 UTC |
PETERSMEYER GARY SDirector
|
GrantRestricted Stock Units · Derivative | 1,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032455 · form4.xml · derivative · entry 2 PETERSMEYER GARY S · CIK 0001206986 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570 Underlying: Common Stock · 1,570 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2016 Filed Nov 16, 2017 23:16 UTC |
Lindell Jody SDirector
|
GrantRestricted Stock Units · Derivative | 1,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032454 · form4.xml · derivative · entry 4 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570 Underlying: Common Stock · 1,570 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2016 Filed Nov 16, 2017 22:54 UTC |
KOZY WILLIAM ADirector
|
GrantRestricted Stock Units · Derivative | 1,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032443 · form4.xml · derivative · entry 2 KOZY WILLIAM A · CIK 0001221785 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570 Underlying: Common Stock · 1,570 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2016 Filed Nov 16, 2017 22:47 UTC |
Jay ColleenDirector
|
GrantRestricted Stock Units · Derivative | 1,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032441 · form4.xml · derivative · entry 2 Jay Colleen · CIK 0001670561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570 Underlying: Common Stock · 1,570 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:59 UTC |
RUBENSTEIN ALLAN EDirector
|
GiftCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-064667 · form4.xml · nonDerivative · entry 1 RUBENSTEIN ALLAN E · CIK 0001182773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,794 Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:56 UTC |
Golden RandalVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-064093 · form4.xml · derivative · entry 3 Golden Randal · CIK 0001598001 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244 Underlying: Common Stock · 123 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F1 · price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F3 · derivative.exercise_date: Grant Date 10/1/2013 RSU Vesting Date: The grant vests in equal portions on the following dates: 10/1/2014, 10/1/2015, 10/1/2016, 10/1/2017 and 10/1/2018. F4 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:56 UTC |
Golden RandalVP, General Counsel
|
Tax withholdingCommon Stock | 47 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-064093 · form4.xml · nonDerivative · entry 2 Golden Randal · CIK 0001598001 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,120 F2 · shares: 10/1/16 RSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 10/3/16) of $177.75 was used. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:56 UTC |
Golden RandalVP, General Counsel
|
Exercise / conversionCommon Stock | 123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-064093 · form4.xml · nonDerivative · entry 1 Golden Randal · CIK 0001598001 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. Read SEC document |
| September 21, 2016 Filed Sep 22, 2016 22:47 UTC |
WEISS ROBERT SDirector · President & CEO
|
GiftCommon Stock | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-063086 · form4.xml · nonDerivative · entry 1 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,432 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.